geniposide has been researched along with Cirrhosis, Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hasnat, M; Hassan, HM; Qin, T; Wang, Z; Yuan, Z; Zhang, W; Zhou, Y | 1 |
| Li, J; Lin, X; Xing, YQ | 1 |
| Lee, KY; Park, B; Park, JH; Yoon, J | 1 |
3 other study(ies) available for geniposide and Cirrhosis, Liver
| Article | Year |
|---|---|
Geniposide alleviated bile acid-associated NLRP3 inflammasome activation by regulating SIRT1/FXR signaling in bile duct ligation-induced liver fibrosis.
Topics: Animals; Bile Acids and Salts; Bile Ducts; Chromatography, Liquid; Fibrosis; Inflammasomes; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Sirtuin 1; Tandem Mass Spectrometry | 2023 |
Geniposide, a sonic hedgehog signaling inhibitor, inhibits the activation of hepatic stellate cell.
Topics: Actins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Cell Line; Cell Survival; Collagen Type I; Collagen Type I, alpha 1 Chain; Hedgehog Proteins; Hepatic Stellate Cells; Iridoids; Liver; Liver Cirrhosis; Male; Mice | 2019 |
Effects of geniposide on hepatocytes undergoing epithelial-mesenchymal transition in hepatic fibrosis by targeting TGFβ/Smad and ERK-MAPK signaling pathways.
Topics: Animals; Cell Line; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Hepatocytes; Iridoids; Liver Cirrhosis; MAP Kinase Signaling System; Mice; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2015 |